Jin Wang
20Patents
4h-index
52Co-inventors
66Inventor score
Filing activity: Sep 20, 2003 → Jan 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7374781B2 | Sustained release formulations containing acetaminophen and tramadol | Human Necessities | 25 | Expired |
| US11584955B2 | Application of Cas protein, method for detecting target nucleic acid molecule and kit | Chemistry; Metallurgy | 10 | Active |
| US9447049B2 | Compounds for treatment of cancer | Chemistry; Metallurgy | 10 | Active |
| US10022356B2 | Compounds for treatment of cancer | Human Necessities | 7 | Active |
| US10525037B2 | Compounds for treatment of cancer | Human Necessities | 3 | Active |
| US11084811B2 | Compounds for treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10040998B2 | Liquid crystal composition and application thereof | Chemistry; Metallurgy | 1 | Active |
| US12180539B2 | Application of CAS protein, method for detecting target nucleic acid molecule and kit | Emerging Cross-Sectional Technologies | 1 | Active |
| US10077477B2 | Serum/plasma MicroRNAs and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9533035B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
| US10487301B2 | Reaction tube for nucleic acid amplification capable of controlling liquid circulation path | Performing Operations; Transporting | 0 | Active |
| US12083472B1 | Device and method for capturing carbon dioxide and producing organic weak acid salt | Emerging Cross-Sectional Technologies | 0 | Active |
| US10537629B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
| US11465987B2 | Compounds for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12104204B2 | Use of high-temperature-resistant Cas protein, and method and reagent kit for detecting target nucleic acid molecule | Emerging Cross-Sectional Technologies | 0 | Active |
| US9909127B2 | Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US9365771B2 | Liquid crystal compounds containing a difluoromethyleneoxy linking group that hydrogen substituted by deuterium, their preparation and application | Chemistry; Metallurgy | 0 | Active |
| US10011880B2 | Serum/plasma MicroRNAs and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10240150B2 | Avian influenza virus miRNA, and appraisal, detection, and application thereof | Physics | 0 | Active |
| US9943586B2 | Truncated L1 protein of human papillomavirus type 11 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.